Background: Previous epidemiologic and toxicological studies provide some inconsistent evidence that exposure to phthalates may affect thyroid function and growth hormone homeostasis. Objective: To assess the relations between exposure to phthalates and indicators of thyroid function and growth hormone homeostasis disturbances both among adults and minors. Methods: We conducted a population-based cross-sectional study of 279 Taiwanese adults (≥18 years old) and 79 minors ( < 18 years old) in 2013. Exposure assessment was based on urinary biomarkers, 11 phthalate metabolites measured by using online liquid chromatography/tandem mass spectrometry. Indicators of thyroid function included serum levels of thyroxine (T 4 ), free T 4 , triiodothyronine, thyroid-stimulating hormone, and thyroxine-binding globulin (TBG). Growth hormone homeostasis was measured as the serum levels of insulinlike growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP3). We applied multivariate linear regression models to examine these associations after adjusting for covariates. Results: Among adults, serum T 4 levels were negatively associated with urinary mono-(2-ethyl-5-hydroxyhexyl) phthalate (β=−0.028, P=0.043) and the sum of urinary di-(2-ethylhexyl) phthalate (DEHP) metabolite (β=−0.045, P=0.017) levels. Free T 4 levels were negatively associated with urinary mono-ethylhexyl phthalate (MEHP) (β=−0.013, P=0.042) and mono-(2-ethyl-5-oxohexyl) phthalate (β=−0.030, P=0.003) levels, but positively associated with urinary monoethyl phthalate (β=0.014, P=0.037) after adjustment for age, BMI, gender, urinary creatinine levels, and TBG levels. Postive associations between urinary MEHP levels and IGF-1 levels (β=0.033, P=0.006) were observed. Among minors, free T 4 was positively associated with urinary mono benzyl phthalate levels (β=0.044, P=0.001), and IGF-1 levels were negatively associated with the sum of urinary DEHP metabolite levels (β=−0.166, P=0.041) after adjustment for significant covariance and IGFBP3. Conclusions: Our results are consistent with the hypothesis that exposure to phthalates influences thyroid function and growth hormone homeostasis.
Introduction
Phthalates are a family of industrial chemicals widely used as plasticizers and softeners in various commercial products including food packaging materials, medical equipment, toys, furniture, and cosmetics (Koch and Calafat, 2009 ). Routes of exposure to phthalates includes ingestion, dermal contact, and inhalation. Phthalates are rapidly metabolized to their respective monoesters and subsequent oxidative metabolites, which are excreted in the urine and feces (Dirven et al., 1993; Schmid and Schlatter, 1985) . Urinary phthalate metabo-lites are broadly used as biomarkers of phthalate exposure in humans (Koch and Calafat, 2009; Wittassek et al., 2007) . In 2011, a food scandal involving DEHP-tainted products (such as DEHP, DnBP and di-i-butyl phthalate (DiBP) in beverage, food and nutrition supplements) occurred in Taiwan (Wu et al., 2012) . Most contaminant products were removed and immediate regulation was activated within two months. However, the phthalate exposure levels in Taiwanese people significantly decreased after this episode according to our biomonitoring survey (Huang et al., 2015) . Whether actual phthalate exposure levels cause adverse health effects in the general Taiwanese population is still unknown.
Thyroid hormones are essential for many physiological processes, including fetal and child growth and development, energy balance, metabolism, and other functions of the nervous, cardiovascular, and reproductive systems of children and adults (Diamanti-Kandarakis et al., 2009; Miller et al., 2009) . Recently, experimental studies have demonstrated that exposure to phthalates such as DEHP can affect thyroid signaling through numerous potential mechanisms such as sodium-iodide symporter (NIS) and growth (Boas et al., 2006; Liu et al., 2015) . Information on phthalate exposure and thyroid function, as well as insulin-like growth factor 1 (IGF-1), in human studies is limited. Previous studies have indicated inverse relationships between urinary DEHP metabolites and serum thyroxine (T 4 ), free T 4 , and triiodothyronine (T 3 ) in adults, despite a positive correlation with thyroid-stimulating hormone (TSH) (Meeker et al., 2007; Meeker and Ferguson, 2011) . Some studies have revealed that urinary DEHP or DBP metabolites are negatively associated with serum T 3 , free T 3 , and IGF-1 in minors (Boas et al., 2010) as well as TSH in a DEHP-tainted child group (Wu et al., 2013) ; by contrast, other studies have reported a positive relationship between DEHP metabolites and T 3 (Meeker and Ferguson, 2011) . However, the effects of exposure to phthalates on thyroid hormones and IGF-1 levels in adults and children are unclear, and the results remain inconsistent. Therefore, the purpose of the present study was to explore the relationships between exposure to phthalates and serum thyroid function and IGF-1 levels in Taiwanese adults and minors.
Methods

Study population
The source population comprised the general Taiwanese population. The study population was selected based on the sampling frame and procedures used in recruitment for the Nutrition and Health Survey in Taiwan (NAHSIT) (Pan et al., 2011) . All detailed sampling procedures have been described in our previous studies (Huang et al., 2015) . In brief, according to the population density and urbanization of each city in Taiwan, we selected seventeen townships of eleven cities or counties in the northern region (ex.: Taipei and New Taipei City), central region (ex.: Taichung and Chia-Yi City), southern region (ex.: Kaohsiung City), eastern region (ex.: Hua-Lien County) and remote island region (Peng-Hu County) of Taiwan between May 2013 and December 2013. All participants were required to be Taiwanese, aged 7 years or older, excluding pregnant and breast-feeding women, individuals with severe disease (ex.: cancer patients), foreigners, and citizens in hospitals or jails. A total of 500 participants were interviewed on the day of the health examination at a community center or elementary school; 394 individuals participated in this study (a response rate of nearly 78%). We excluded 36 participants who provided no blood samples. Ultimately, the study population comprised 279 adults and 79 minors. An interviewer-administered questionnaire was also used to obtain information regarding individual characteristics (age, gender, residence, and education), health, environmental exposures (cigarette smoking and insecticide usage), and lifestyle (plastic product and personal care products usage). This study was approved by the Research Ethics Committee of the National Health Research Institutes (No. EC1020206) in Taiwan. Written informed consent from each participant and additional signatures from the parents of minors were obtained prior to study enrollment.
Exposure assessment
Assessment of exposure to 7 commonly used phthalates, DEHP, DnBP, DiBP, DEP, di-isononyl phthalate (DiNP), benzyl butyl phthalates (BBzP), and dimethyl phthalate (DMP), were based on the levels of biomarkers i.e. metabolites of these phthalates in urine. A firstmorning urine sample (20 mL) was collected from each participant by using a PP container, transferred to an acetonitrile-prewashed amber glass bottle and stored at −80°C. We quantified 11 urinary phthalate metabolites including mono-ethylhexyl phthalate (MEHP), mono-(2-ethyl-5-oxo-hexyl) phthalate (MEOHP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP), mono-(2-carboxymethylhexyl) phthalate (MCMHP), monon-butyl phthalate (MnBP), mono-iso-butyl phthalate (MiBP), monoethyl phthalate (MEP), mono-isononyl phthalate (MiNP), mono-benzyl phthalate (MBzP), and mono-methyl phthalate (MMP). The concentrations of the phthalate metabolites were determined using online liquid chromatography/tandem mass spectrometry (Agilent 1200/API 4000, Applied Biosystems, Foster City, CA, USA), as in the Taiwan Environmental Survey for Toxicants (TESTs) study (Huang et al., 2015) . The urinary concentrations of the 11 phthalate metabolites were determined as ng/mL and μg/g creatinine. The molar sum (nmole/mL or μmole/g creatinine) of the DEHP metabolites (ΣDEHPm) was calculated by adding the molar concentrations of 5 metabolites: MEHP, MEHHP, MEOHP, MECPP, and MCMHP. The molar sum (nmole/mL or μmole/g creatinine) of the DBP metabolites (ΣDBPm) was calculated by adding the molar concentrations of 2 metabolites: MiBP and MnBP. The limit of detection (LOD) for MEHP, MEOHP, MEHHP, MECPP, MCMHP, MnBP, MiBP, MEP, MiNP, MBzP, and MMP were 0.7, 0.3, 0.3, 0.3, 0.1, 1, 1, 0.3, 0.1, 0.3, and 0.3 ng/mL, respectively. When the phthalate metabolite levels were lower than the LOD, we calculated our data as half of the LOD value. One blank, repeated quality control (QC) sample was included in each batch of analyzed samples. Concentrations of blank samples was to be less than 2 fold the method detection limit. The QC sample was spiked in pooled urine samples with a mixture of phthalate metabolite standards (20-50 ng/mL) in each sample. The relative percent difference for the repeated sample, as well as recovery of the QC sample, was to be less than ± 30%. Urinary creatinine levels were measured by spectrophotometric methods, with picric acid as a reactive compound for reading at 520 nm measurement (Beckman; DXC 800).
Outcome assessment
The outcomes of interest were thyroid function and growth hormone homeostatsis. Thyroid function was measured as the serum concentrations of thyroxine (T 4 ), free T 4 , triiodothyronine (T 3 ), thyroid-stimulating hormone (TSH), and thyroxine-binding globulin (TBG). Growth hormone homeostasis was measured as the serum levels of insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP3). The morning blood sample from each participant was collected and immediately centrifuged for 20 min at 4°C, and then stored at −80°C until analysis. All analyses were carried out blinded for the technician and in random order, and analyzed by a Taiwan Accreditation Foundation-certified laboratory (No. 1447 and 1673) , recognized by the International Laboratory Accreditation Cooperation Mutual Recognition Arrangement (Huang et al., 2016a (Huang et al., , 2016b . The serum levels of T 4 , T 3 , free T 4 , and TSH were quantified using a chemiluminescent microparticle immunoassay on Beckman Coulter's UniCel (R) DxI 800 Immunoassay System (Beckman Coulter Inc., Brea, CA, USA). The assay sensitivities for T 3 , T 4 , free T 4 , and TSH were 0.25 ng/mL, 1.0 μg/dL, 0.4 ng/dL, and 0.0025 μIU/mL, respectively. Serum TBG was measured using the immunoenzymometric assay with ACCUBIND ELISA Microwells (Monobind Inc., Product Code 3525-300). Serum IGF-1 was measured using an immunoradiometric assay (IRMA) kit (IGF-IRIACT, Cis Bio, Gif-sur-Yvette, France), and serum IGFBP3 was measured using an IRMA kit (ACTIVE IGFBP3 IRMA, Diagnostic Systems Laboratories Inc., Webster, TX, USA). The assay sensitivities for TBG, IGF-1, and IGFBP3 were 1.0 μg/mL, 1 ng/mL, and 0.5 ng/mL, respectively. The laboratory's reference ranges for adults of TSH, T 3 , T 4 , Free T 4 , and TBG were 0.35 -4.94 μIU/mL, 58 -159 ng/dL, 4.87 -11.72 μg/dL, 0.70 -1.48 ng/dL, and 15.8 -25.4 μg/mL, respectively. Most of thyroid hormones in the study population were within reference range. The proportion that is outside the laboratory's range for adults of TSH, T 3 , T 4 , free T 4 , and TBG is 6%, 6%, 4%, 6%, and 29%, respectively.
Statistical methods
Descriptive statistics on the participant demographics were tabulated with the distributions of phthalate metabolite concentrations, thyroid hormones, and IGF-1 levels. Because of significant differences in some thyroid hormone and IGF-1 levels in minors compared with adults, we separated our data set into 2 groups in subsequent analyses. All levels of hormones and phthalate metabolites were transformed using the natural logarithm (Ln) to meet the normality assumption. Principal component analysis (PCA) was applied to assess the potential sources of exposure to different phthalates. Physiological factors or variables significantly correlated with urinary phthalate metabolites or thyroid hormones were included in the multiple regression model. We then constructed full multivariable linear regression models with serum thyroid hormones or IGF-1 levels as the dependent variable and individual ln-transformed urinary phthalate metabolite concentrations as a predictor, with age (continuous variable), gender (dichotomous), BMI (continuous), urinary creatinine levels (continuous), and ln-transformed serum TBG or IGFBP3 (continuous) as covariates. These covariates were selected based on previous studies (Boas et al., 2010; Meeker and Ferguson, 2011 ) and a 10% change-in-estimated criterion (Rothman et al., 2008) . In addition, we utilized the quartile of urinary phthalate metabolite levels to assess the nonlinear relationship between phthalate exposure and hormone levels. A subgroup analysis was conducted to exclude 45 adults with a self-reported history of other endocrine diseases. No differences were observed between adults with and without including 45 adults with a self-reported history of other endocrine diseases. Finally, we concluded these participants to present the results of this study. A P value of < 0.05 was considered statistically significant. SAS Version 9.1.3 was used for all statistical analyses.
Results
Study population
The study population included 376 subjects, 279 (74.2%) adults and 97 (25.8%) minors. The mean age and BMI in adults were 53.4 years (SD 17.3) and 24.8 (SD 4.4), respectively. Approximately half of them were women (53.8%). A high percentage of participants were non-smokers (74.8%), did not consume alcohol (86.9%), or chew betel nuts (93.2%), or did not use pesticides at home (74.9%). Approximately half of the minors were boys (59.6%). The mean age and BMI in minors were 12.6 years (SD 3.2) and 20.6 (SD 5.3), respectively. The detailed characteristics of all participants are presented in Table 1 .
Distributions of the biomarkers of exposure and measures of outcome
Distributions of urinary phthalate metabolite and hormone levels among adults and minors are compared in Table 2 . The geometric mean (GM) levels of urinary MBzP, MEHHP, MEOHP and ΣDEHPm in adults were significantly lower than those found in minors. No significant differences in the GM levels of other urinary phthalate metabolites were observed between adults and minors. The GM levels of serum T 3 , IGF-1, and IGFBP3 in adults were significantly lower than those in minors (103.6 vs 132.8 ng/dL for T 3 ; 173.6 vs 398.5 ng/dL for IGF-1; 3591 vs 4360 ng/mL for IGFBP3), whereas the serum TSH levels in adults were significantly higher than those in minors (1.54 vs 1.41 μIU/mL). The GM levels of serum T 4 , free T 4 , and TBG were comparable between adults and minors.
3.3. Relationships between biomarkers of phthalate exposure and levels of thyroid hormones Table 3 and Table 4 present the relations between biomarkers of exposure and measures of thyroid function and growth hormone homeostasis separately for adults and minors, adjusted for core covariates in linear regression. In minors, the serum T 3 levels were significantly related to urinary MEHP levels (β=0.030, P=0.026). None of the concentrations of urinary phthalate metabolites explained T 3 levels in adults. In adults, the serum T 4 levels were inversely related to both the levels of urinary MEHHP and ΣDEHPm (β=−0.028, P=0.043 for MEHHP; β=−0.045, P=0.017 for ΣDEHPm). In minors, no associations between levels of any urinary phthalate metabolites or serum T 4 in minors were observed. In adults, the levels of serum-free T 4 were positively related to the levels of both urinary MEP and MBzP (β=0.014, P=0.037 for MEP; β=0.018, P=0.027 for MBzP), and inversely to the levels of urinary MEHP and MEOHP (β=−0.013, P=0.042 for MEHP; β=−0.030, P=0.003 for MEOHP). Positive associations between levels of urinary MBzP and serum-free T 4 also in minors were found (β=0.044, P=0.001). We found no relations between the levels of any urinary phthalate metabolites or serum TSH among adults and minors.
Relationships between biomarkers of phthalate exposure and levels of growth hormones
We found a positive association between levels of urinary MEHP and IGF-1 in adults (β=0.033, P=0.006), but no such association was present in minors. In minors, the levels of IGF-1 were related to the levels of urinary ΣDEHPm (β=−0.166, P=0.041). Figs. 1 and 2 show the nonlinear relationships between phthalate metabolites and hormone levels according to the quartiles of urinary phthalate metabolite levels in Taiwanese adults and minors. For adults, we found significant differences in the fourth (Q4) and third (Q3) quartiles of MEHHP (β=−0.120, P=0.001 for Q4 of MEHHP; β=−0.086, P=0.016 for Q3 of MEHHP) and Q4 of ΣDEHPm (β=−0.084, P=0.021) compared with the first (Q1) quartile for the T 4 levels in adults. Compared with Q1 for the free T 4 levels in adults, significant differences in Q4 and the second (Q2) quartile of MEHP (β=−0.093, P=0.004 for Q4 of MEHP; β=−0.074, P=0.023 for Q2 of MEHP) were observed. Serum-free T 4 levels in Q4 and Q3 of MEP (β=0.068, P=0.043 for Q4 of MEP; Table 3 Adjusted regression coefficient and 95% CI for change in serum thyroid and growth hormones in relation to unit-increased in Ln-phthalate metabolites (μg/g creatinine or ng/mL) in Taiwanese 
Table 4
Adjusted regression coefficient and 95% CI for change in serum thyroid and growth hormones in relation to unit-increased in Ln-phthalate metabolites (μg/g creatinine or ng/mL) in Taiwanese β=0.071, P=0.028 for Q3 of MEP) were higher than those in Q1. We observed significant differences in Q4 and Q2 of MEHP (β=0.158, P=0.006 for Q4 of MEHP; β=0.230, P < 0.001 for Q2 of MEHP) compared with Q1 for the IGF-1 levels. For minors, we found that serum T3 levels in Q4 of MEHP (β=0.132, P=0.034) and free T 4 levels in Q4 of MBzP (β=0.141, P=0.014) were higher than those in Q1. No significant differences in the quartile of ΣDEHPm for the IGF-1 levels were found.
Discussion
This is the first study to evaluate systematically the effects of phthalate exposure on measures of thyroid function and growth hormone homeostasis in the general Taiwanese adult and minor populations. We found evidence of negative associations between urinary MEHHP or ΣDEHPm levels and serum T 4 , and between urinary MEHP or MEOHP and serum free T 4 in Taiwanese adults, whereas we found a positive association between urinary MEP and serum free T 4 . Some of our results are consistent with those of relevant studies (Supplemental Table S1 ). Meeker et al. (2007) first reported a significantly inverse relationship between MEHP and free T 4 levels in 408 American men (Meeker et al., 2007) , meanwhile some studies showed inverse relationship between MnBP and serum T 4 levels in pregnant Taiwanese women (Huang et al., 2007 (Huang et al., , 2016a . Meeker and Ferguson (2011) studied 1364 adults aged ≥20 years from the 2007-2008 National Health and Nutrition Examination Survey (NHANES) and found inverse relationships between DEHP metabolites and T 4 levels (Meeker and Ferguson, 2011) . DEHP acts as a thyroid antagonist (Shen et al., 2009; Shi et al., 2011) and causes a change in iodine uptake by altering the sodium-iodine symporter in vitro studies (Wenzel et al., 2005) . A previous study of zebrafish (Danio rerio) embryos treated with diverse concentrations of MEHP demonstrated that whole-body T 4 levels were significantly decreased, probably through the upregulation of genes related to thyroid hormone metabolism (Zhai et al., 2014) . Liu et al. showed that DEHP could reduce thyroid hormones by influencing biosynthesis through biotransformation, bio-transport, receptor levels, and metabolism of thyroid hormones in male rats (Liu et al., 2015) . However, we also found positive relationships between urinary MEP and free T 4 levels, which were inconsistent with previous studies (Brown et al., 1978; Pereira et al., 2007) . Although personal care products and cosmetics are potential sources of DEP exposure in Chinese adults (Gao et al., 2016) , little information is available on whether frequent DEP exposure alters thyroid hormones. Mechanistic studies are necessary to elucidate our findings.
The results for the participants aged 7-18 years are inconsistent with those for the adults. Although the sample size of this age group was relatively small, we derived evidence of significantly positive associations between urinary MEHP levels and serum levels of T 3 . Meeker and Ferguson (2011) also reported positive associations between DEHP metabolites and T 3 and TSH levels in 329 adolescents aged 12-19 years from the 2007-2008 NHANES (Meeker and Ferguson, 2011) . However, Boas et al. (2010) found that T 3 and free T 3 were inversely correlated with crude phthalate concentrations, including MEP and DEHP metabolites among 845 children (aged 4-9 y) in Denmark (Boas et al., 2010) . Recently, Wu et al. (2013) studied 60 children in Taiwan aged younger than 10 years (Wu et al., 2013) . They reported that TSH and T 3 levels decreased when children were exposed to high levels of phthalate-tainted foodstuffs. In addition, de Cock et al. (2014) found no significant associations between DEHP metabolites assessed in cold blood and serum T 4 levels in a Dutch prospective cohort study of 86 infants (de Cock et al., 2014) . Therefore, differences in study design, age group, sample size, exposure profiles, and covariates could result in inconsistent findings.
Our results also showed that urinary ΣDEHPm levels were negatively associated with IGF-1 levels in minors, but urinary MEHP levels were positively associated with IGF-1 levels in adults. Boas et al. (2010) reported inverse relationships between urinary ΣDEHP levels and IGF-1 levels in 845 children aged 4-9 years (Boas et al., 2010) , which was consistent with our findings. We also found different effects on IGF-1 levels regarding phthalate exposure in adults and minors. Meeker and Ferguson (2011) observed different effects on thyroid function with regard to phthalate exposure, such as DEHP in adults and adolescents (Meeker and Ferguson, 2011) . Recently, Chang et al. (2015a) demonstrated that urinary MEHP percentages were negatively associated with insulin-like factor 3 (INSL3) in 176 men (Chang et al., 2015a ). In experimental studies, increasing exposure to DEHP in adult rats has decreased the expression levels of INSL3 (Guo et al., 2013; Li et al., 2012) , and exposure to MEHP and MBP appeared to suppress INSL3 gene expression (Pathirana et al., 2011) . However, previous studies of IGF-1 effects have indicated that prenatal exposure to low-dose DEHP may increase levels of the mRNA for IGF-1 (Lin et al., 2008) . Furthermore, phthalates could potentially interact with other endocrine pathways such as the hypothalamic-pituitary axis or androgen biosynthesis. Such complex effects-in addition to the age groupmight contribute to differences in effects. Understanding whether phthalate exposure, such as IGF-1 in adults and minors, could have different effects on growth requires future studies to elucidate these associations and potential biological mechanisms.
Two previous studies did not provide sufficient evidence to assume that urinary phthalate metabolites are associated with TBG or IGFBP3 (Boas et al., 2010; Meeker and Ferguson, 2011) . Thus, these binding proteins are more likely to act as confounders than mediators of the effects of phthalates on thyroid and growth hormone levels. However, our findings show 1) an association between urinary phthalate metabolites (MnBP and MiBP) and TBG and IGFBP3 (Supplemental Table S2 ), and 2) an association between phthalate metabolites and thyroid and growth hormones. These two associations together are consistent with the hypothesis that part of the effect of phthalates on thyroid and growth hormones is mediated by the binding proteins, such as TBG and IGFBP3 (Baron and Kenny, 1986) . However, because of our cross-sectional design, we cannot easily elaborate the temporal relation between phthalate exposure, binding protein concentrations, and thyroid and growth hormones that would strengthen our inference about the role of binding proteins in the causal path. Future studies are needed to elaborate these relationships and the related biological mechanisms.
Based on our PCA results, we found 2 components extracted in adults and minors that accounted for 51.7% and 55.4% of the variability, respectively (Supplemental Fig. S1 ). This indicated 2 major potential exposure sources of phthalate for Taiwanese adults and minors. MEHP, MEHHP, MEOHP, MECCP, and MCMHP were highly correlated with component 1 (PC1), whereas MiBP, MnBP, MBzP, and MiNP were moderately/ highly correlated with component 2 (PC2). These results indicate that PC1 is dominated by the group of DEHP metabolites and PC2 by the group of MiBP, MnBP, MBzP, and MiNP. Our findings are similar to those of the previous study of young Chinese adults (Gao et al., 2016) . DEHP is the most abundant phthalate in foods . Foods may be a major exposure source of phthalates for Taiwanese adults and minors. The sources of MiBP, MnBP, MBzP, and MiNP could be lacquers, varnishes, coatings, and food-packaging materials (Calafat and McKee, 2006; Cao, 2010) . For other metabolites, the major sources of MEP could be personal care products (Bao et al., 2015; Guo et al., 2014) . Regarding the source of MMP, a previous study suggested that the levels of DMP in milk products, instant noodles, cakes, cookies, and salted eggs were higher than those in other foods . However, there may still be other unknown sources of exposure.
Most of the thyroid hormone levels in our study population were within the reference range, although we found that T 4 , free T 4 , TBG, and IGF1 levels were significantly different between the regions of residence (Supplemental Table S3 ) as compared with those of the participants living in Northern Taiwan. Further stratified analysis revealed no significantly decreased levels of T 4 or free T 4 varied according to insecticide use in our participants (Supplemental Table  S4 ). Furthermore, we found no differences between urinary phthalate metabolites levels and insecticide use at home (Supplemental Table S5 ) in our participants. Thus, insecticide use is less likely to have affected our results. The consumption of iodine intake in our subjects could be another crucial confounder. From 1966 From -2004 , the Taiwan government required salt manufacturers to add iodine to their products. A NAHSIT survey reported no significant changes in iodine consumption, but sodium consumption decreased in the general Taiwanese population from 1993 to 2008 (Pan et al., 2011) . In addition, other early regional data in Taipei revealed that only 3% of participants excreted less than 50 μg of iodine/g creatinine (mild deficiency), but 42.7% of the population excreted more than 300 μg of iodine/g creatinine (Lin et al., 1991) . According to a more recent report from NAHSIT (funded by the Taiwan Ministry of Health and Welfare), the median level of urinary iodine in the Taiwanese general population (NAHSIT 2004 (NAHSIT -2008 was 100 μg of iodine/g creatinine (WHO optimal: 100-199 μg), at the lowest value suggested by the WHO (Chang, 2015b) . Moreover, previous studies have indicated that iodine excretion had a negligible impact on the relationships between phthalate metabolites and thyroid hormone levels (Mendez and Eftim, 2012) . Thus, the consumption of iodine in our participants is less likely to have biased our results.
There were several limitations to this study. First, the crosssectional study design limited the causal inference from the observed associations between phthalate exposure, thyroid function, and IGF-1 measures. Second, only one urine sample per participant was assessed for phthalate metabolite concentrations, which may not be representative of the average body burden of the participant because of the short half-lives of these chemicals. Nevertheless, previous studies have shown that single-spot urine samples of phthalate levels may be moderately representative of long-term average exposure (Hauser et al., 2004; Teitelbaum et al., 2008) . Similarly, we collected only one serum sample per participant to be analyzed for thyroid hormones and IGF-1 levels. These hormone levels may vary in an individual over time. However, Andersen et al. (2002) reported that thyroid hormone measures in an individual are retained within relatively narrow limits over time (Andersen et al., 2002) . Finally, we did not collect information concerning the iodine or selenium status of our participants, which may be critical because deficiencies in these trace elements can impair normal thyroid hormone function (Zimmermann and Kohrle, 2002) . However, no subjects had a goiter or thyroid-related diseases, according to their self-reported questionnaire. We have no reason to expect that an iodine or selenium deficiency would be associated with phthalate exposure or that any deficiencies in these substances would affect the precision of the estimated effects rather than the estimates themselves (Schisterman et al., 2009 ). Serum-free T 4 levels measured using chemiluminescent immunoassays in the present study could have been influenced by binding protein concentrations. Because we explored the associations between urinary phthalate metabolites levels and free T 4 levels adjusted for TBG levels, the effects from binding protein concentrations in the present study could be limited.
Conclusions
Overall, our results provide evidence that exposure to environmental phthalates could influence the thyroid hormones and growth homeostasis in both adults and minors. More detailed research of different populations with various lifestyles is necessary to verify the specific findings and establish the temporal relationships between markers of exposure and effects, and actuate the potential clinical and public health implications of these associations.
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